Overview
All of DR.Cure’s research and development activities are aimed at improving the quality of human life. DR.Cure promises to establish itself as a leading company in the global nanotherapeutcis industry through constant challenges and focused research.

DR.Cure is dedicated to researching nanotechnology-based radiotherapeutic nanoparticles and developing effective cancer treatments.
By leveraging innovative drug delivery systems and nanomedicine, we maximize treatment efficacy and continuously validate our expertise through patent applications and academic research.

Swipe the screen to the right
Class Nanomedicines Target diseases Hit discovery Lead
optimization
Preclinical Clinical
Radiotherapeutics
for cancers
DC-101 Rectal cancer
DC-102 Liver cancer
Nanomedicines
for inflammatory
diseases
DC-201 Arthritis